45 Years of HIV Progress at Risk as Global Funding Faces Deep Cuts.

The HIV Epidemic: A Lasting Global Health Crisis

According to Vox - Загальний: First identified in 1981, the HIV epidemic has grown into one of the most severe public health challenges worldwide. Over its course, more than 44 million people have died from the virus. Yet, thanks to major treatment breakthroughs, HIV-related deaths have dropped by 70% from their peak. In 2024 alone, 1.3 million people were newly infected, underscoring the urgent need to sustain the fight against the disease.

Current Status of the HIV Response

Today, roughly 30 million individuals are receiving antiretroviral therapy, made possible by advances in medical science. The development of long-acting prevention drugs—administered as a single injection every six months—opens up new possibilities for stopping the spread of HIV. Moreover, the prospect of an effective HIV vaccine is now a realistic goal that could dramatically reduce transmission.

Despite these gains, the outlook remains troubling. Declining global funding and waning political commitment threaten to undo decades of progress. The question of whether we have truly conquered AIDS remains unanswered, and many nations—particularly South Africa—could lose access to life-saving medicines. The suspension of initiatives like PEPFAR could result in millions of additional deaths, including 200,000 children under the age of five who may die this year alone due to aid reductions.

In short, the 45-year battle against HIV stands as one of humanity’s greatest achievements, yet it now hangs in the balance. Sustained efforts are essential to prevent further losses and ensure that treatment reaches everyone in need.

This news highlights the critical importance of continued funding for HIV/AIDS programs. Without adequate support, the hard-won gains of recent decades could be lost.

The global community—including national governments and international organizations—must remain actively engaged in combating this epidemic. Ensuring access to treatment and prevention for all, especially in the world’s most vulnerable regions, is an ongoing responsibility.